Viewing Study NCT00251368


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-01 @ 11:53 AM
Study NCT ID: NCT00251368
Status: COMPLETED
Last Update Posted: 2011-03-10
First Post: 2005-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
Sponsor: Dana-Farber Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 94-115
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View